Will Retatrutide (new obesity drug) be FDA approved by the end of 2024?
Basic
6
Ṁ456Jan 1
4%
chance
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get
1,000
and3.00
Sort by:
Phase 3 trial is estimated to complete in late 2025: https://classic.clinicaltrials.gov/ct2/show/NCT05882045
Related questions
Related questions
Will Retatrutide (new obesity drug) be FDA approved by the end of 2025?
46% chance
Will Retatrutide (new obesity drug) be FDA approved by the end of 2026?
85% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
35% chance
Will aducanumab be withdrawn by the FDA by 2025?
47% chance
Will the FDA approve MDMA as a treatment for PTSD by the end of 2024?
4% chance
Will AOH1996 be FDA approved before 2040?
44% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
66% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
64% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will Ozempic be FDA approved for use in type 1 diabetes patients by end of 2024?
11% chance